| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 139 |
| 1 | PREDNISONE | 128 |
| 2 | METHOTREXATE | 125 |
| 3 | TACROLIMUS | 101 |
| 4 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 91 |
| 5 | TACROLIMUS OINTMENT 0.1% | 91 |
| 6 | MYCOPHENOLATE MOFETIL | 70 |
| 7 | ADALIMUMAB | 67 |
| 8 | RITUXIMAB | 63 |
| 9 | INFLIXIMAB | 57 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TALIMOGENE LAHERPAREPVEC | 11 | 0.0069 |
| 1 | ALDESLEUKIN | 3 | 0.0024 |
| 2 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 16 | 0.0020 |
| 3 | BENDAMUSTINE HYDROCHLORIDE | 16 | 0.0019 |
| 4 | AZATHIOPRINE SODIUM | 4 | 0.0016 |
| 5 | SIROLIMUS | 19 | 0.0014 |
| 6 | BENDAMUSTINE HCL | 17 | 0.0011 |
| 7 | FINGOLIMOD HYDROCHLORIDE | 5 | 0.0010 |
| 8 | TOFACITINIB CITRATE | 13 | 0.0010 |
| 9 | ADALIMUMAB-FKJP | 39 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 195 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 134 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 125 |
| 3 | Kinase Inhibitor [EPC] | 99 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 66 |
| 5 | Janus Kinase Inhibitor [EPC] | 66 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 63 |
| 7 | Alkylating Drug [EPC] | 46 |
| 8 | Purine Antimetabolite [EPC] | 40 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 39 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lymphocyte Growth Factor [EPC] | 3 | 0.0024 |
| 1 | Sulfonamide Antibacterial [EPC] | 3 | 0.0008 |
| 2 | Interleukin-1 Receptor Antagonist [EPC] | 10 | 0.0006 |
| 3 | Antimetabolite Immunosuppressant [EPC] | 12 | 0.0006 |
| 4 | Cannabinoid [EPC] | 4 | 0.0005 |
| 5 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 6 | Neonatal Fc Receptor Blocker [EPC] | 2 | 0.0005 |
| 7 | Selective T Cell Costimulation Blocker [EPC] | 2 | 0.0004 |
| 8 | Janus Kinase Inhibitor [EPC] | 66 | 0.0004 |
| 9 | Purine Antimetabolite [EPC] | 40 | 0.0004 |